Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The regulatory role of DPP4 in atherosclerotic disease
Lihua Duan, Xiaoquan Rao, Chang Xia, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 589
The sex-dependent response to psychosocial stress and ischaemic heart disease
Tessa J. Helman, John P. Headrick, Nicolas J. C. Stapelberg, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 21
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Allison B. Herman, Dimitrios Tsitsipatis, Carlos Anerillas, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 19
Bile acids and incretins as modulators of obesity-associated atherosclerosis
Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Incretin drugs as modulators of atherosclerosis
Enrique Gallego-Colón, Wojciech Wojakowski, Tomasz Francuz
Atherosclerosis (2018) Vol. 278, pp. 29-38
Closed Access | Times Cited: 36
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin
Annayya R. Aroor, Camila Manrique‐Acevedo, Vincent G. DeMarco
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Neck Circumference Positively Related with Central Obesity and Overweight in Turkish University Students: A Preliminary Study
İsmail Özkaya, Aydın Tunçkale
Central European Journal of Public Health (2016) Vol. 24, Iss. 2, pp. 91-94
Open Access | Times Cited: 28
Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes
Shiliang Li, Chun Qin, Shichao Cui, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 5, pp. 2348-2361
Closed Access | Times Cited: 26
The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities
Rubén Varela‐Calviño, Marta Rodríguez‐Quiroga, Patrícia Dias Carvalho, et al.
IUBMB Life (2021) Vol. 73, Iss. 5, pp. 761-773
Open Access | Times Cited: 17
Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell
Hanyan Zhang, Dandan Sun, Guanzhen Wang, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 511, Iss. 2, pp. 387-393
Closed Access | Times Cited: 18
New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
Chenkai Cui, Xuefei Tian, Linting Wei, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
<p>DPP-4 Inhibitor Linagliptin Ameliorates Oxidized LDL-Induced THP-1 Macrophage Foam Cell Formation and Inflammation</p>
Haoran Wang, Yue Li, Xiaoliang Zhang, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 3929-3940
Open Access | Times Cited: 16
Conversion of M1 Macrophages to Foam Cells: Transcriptome Differences Determined by Sex
Rafael Nambo‐Venegas, Berenice Palacios‐González, Jaime Mas‐Oliva, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 490-490
Open Access | Times Cited: 5
Sitagliptin protects against hypoxia/reoxygenation (H/R)-induced cardiac microvascular endothelial cell injury.
Lianlian Fan, Wei Zhou, Lirong Zhang, et al.
PubMed (2019) Vol. 11, Iss. 4, pp. 2099-2107
Closed Access | Times Cited: 14
Anti-inflammatory interventions to mitigate the cardiovascular risk in metabolic syndrome
Somasundaram Arumugam, Manoj Limbraj Yellurkar, Vani Sai Prasanna, et al.
Elsevier eBooks (2024), pp. 421-437
Closed Access | Times Cited: 1
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: New Oral Medications for the Treatment of Type 2 Diabetes
Devajit Mohajan, Haradhan Mohajan
Innovation in Science and Technology (2024) Vol. 3, Iss. 3, pp. 31-35
Open Access | Times Cited: 1
Gender differences in variables associated with dipeptidyl peptidase 4 genetic polymorphisms in coronary artery disease
Shih-Min Chiang, Kwo‐Chang Ueng, Yi-Sun Yang
Advances in Clinical and Experimental Medicine (2020) Vol. 29, Iss. 10, pp. 1181-1186
Open Access | Times Cited: 11
Alogliptin and Gliclazide Similarly Increase Circulating Endothelial Progenitor Cells in Type 2 Diabetes Patients
Roberto Negro, Eupremio Luigi Greco, Giacomo Greco
Experimental and Clinical Endocrinology & Diabetes (2018) Vol. 127, Iss. 04, pp. 215-219
Closed Access | Times Cited: 8
Saxagliptin protects against hypoxia-induced damage in H9c2 cells
Lili Zhang, Xiaogui Qi, Guowei Zhang, et al.
Chemico-Biological Interactions (2019) Vol. 315, pp. 108864-108864
Closed Access | Times Cited: 8
Sensitive detection of quinoline-derivatized sitagliptin in small volumes of human plasma by MALDI-TOF mass spectrometry
Yishan Li, Wei‐Lung Tseng, Chi‐Yu Lu
Talanta (2020) Vol. 218, pp. 121143-121143
Open Access | Times Cited: 7
A dipeptidil-peptidáz-4-gátlók szerepe a 2-es típusú diabetes mellitus kezelésében napjainkban
Mariann Harangi, Nóra Tóth, Éva Katona
Diabetologia Hungarica (2023) Vol. 31, Iss. 2, pp. 113-122
Open Access | Times Cited: 2
Active Stromal Cell–Derived Factor 1α and Endothelial Progenitor Cells are Equally Increased by Alogliptin in Good and Poor Diabetes Control
Roberto Negro, Eupremio Luigi Greco, Giacomo Greco
Clinical Medicine Insights Endocrinology and Diabetes (2017) Vol. 10, pp. 117955141774398-117955141774398
Open Access | Times Cited: 4
Association of the rs17574 DPP4 Polymorphism with Premature Coronary Artery Disease in Diabetic Patients: Results from the Cohort of the GEA Mexican Study
Gilberto Vargas‐Alarcón, María del Carmen González-Salazar, Adrián Hernández-Díazcouder, et al.
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1716-1716
Open Access | Times Cited: 1
Dipeptidyl Peptidase-4 Inhibitors and Inflammation: Dpp-4 Inhibitors Improve Mean Pleatelet Volume and Gamma Glutamyl Transferase Level
Deniz Avcı
Journal of Biosciences and Medicines (2019) Vol. 07, Iss. 02, pp. 42-53
Open Access
Impairing Senohemostasis by Ablating DPP4 Improves Atherosclerosis
Allison B. Herman, Dimitrios Tsitsipatis, Carlos Anerillas, et al.
SSRN Electronic Journal (2022)
Closed Access
Page 1 - Next Page

Scroll to top